Skip to main content
. Author manuscript; available in PMC: 2014 May 22.
Published in final edited form as: J Rheumatol. 2008 Sep 1;35(11):2179–2186. doi: 10.3899/jrheum.080071

Table 2.

Sample characteristics.

Characteristic SLE Patients Controls p
No. 163 160 ND
Age, yrs, mean ± SD 43.3 ± 11.0 43.5 ± 10.5 0.90
Race, % (n)
    African American 50.3 (82) 50.6 (81) 1.00
    Caucasian 39.3 (64) 39.4 (63)
    Asian 4.9 (8) 5.0 (8)
    Hispanic 4.3 (7) 3.8 (6)
    Other 1.2 (2) 1.2 (2)
CAC, median (IQR) 0 (0–7.2) 0 (0–0) 0.0003
Homocysteine, μmol/l, mean ± SD (n) 10.4 ± 1.4 9.2 ± 1.4 < 0.0001
    African American* 12.1 ± 1.4 (82) 9.7 ± 1.3 (81) < 0.0001
    Caucasian 10.0 ± 1.3 (64) 9.0 ± 1.5 (63) 0.12
Framingham point scores, median (IQR) (n) 8 (3–13) (161) 8 (2–12) (156) 0.39
GFR, ml/min/1.73m2, mean ± SD 90.0 ± 32.5 94.5 ± 20.8 0.14

CAC: coronary artery calcification; GFR: glomerular filtration rate. ND: not determined; IQR: interquartile range.

*

African American case vs Caucasian case, p = 0.0009; African American control vs Caucasian control, p = 0.21.